Try our Advanced Search for more refined results
Life Sciences - July, 2013
274 articles
- J&J, OraPharma Seek Court's OK On Arbitration Award
- 3 Pitfalls To Avoid As ACA Sunshine Act Takes Effect
- Cyberonics Settles $200M Suit Over Therapy System Patents
- FDA Diabetes Drug Inquiry Finds No Cancer Risks
- Dems Move To Toughen Supplement Labeling Requirements
- Patent Holders Should Bear Burden Of Proof, High Court Told
- Congress Must Clarify FDA Oversight On Compounding: GAO
- ITC To Review ClearCorrect Infringement Ruling
- Suit Over Mumps Vaccine Shows No False Claims, Merck Says
- A Post-Actavis Approach To Reverse Payment Settlements
- Deals Rumor Mill: KKR, Accenture, Soros
- AstraZeneca Inks $815M Deal To Develop Anemia Drug
- KKR To Buy Another Clinical Research Co., Plans Merger
- SAC Class Plaintiffs Urge Approval Of $600M SEC Settlement
- Shareholders Sue To Block $8.5B Actavis, Warner Chilcott Deal
- Appeals Court OKs $2.7M Royalty Verdict Against Biomet Units
- Roche Loses Bid To Appeal Accutane Judge's Recusal Ruling
- Cubist Inks Deal To Buy Trius, Optimer For Up To $1.6B
- Judge Won't Toss $100M Trade Secret Suit Against Akorn
- Patients Get FDA's Ear, Opening Door To Relaxed Approvals
- FDA Details Mandatory Drug Warning Label Updates
- Wyeth Paying $491M To End Criminal, Civil Rapamune Cases
- Supplement Maker Pushes To Keep $4M Malpractice Suit Alive
- Deals Rumor Mill: Roche, Invensys, Rio Tinto
- CORRECTED: State Law Claims In Philly Reglan Suits Survive Mensing
- An Insider's View Of 11th Circ. Patent Dispute Forum Case
- PE-Backed Kinetic Drops $485M On UK Wound Care Biz
- Herbalife Urges Judge To Toss 'Pyramid Scheme' Class Action
- Essilor Pays $2B For PPG's Stake In Polarized Lens Maker
- Eli Lilly Dodges More Claims In Darvocet, Darvon MDL
- Accentia Faces Investor Suit Over Lymphoma Vaccine
- Telegraph Hill Closes Health Care VC Fund At $310M
- Teva MS Drug Patent Backed By UK High Court In Mylan Row
- Husch Blackwell Snags IP Partner From Troutman Sanders
- SEC's New Focus On Accounting Fraud: What's On Its Radar?
- LA Atty Sues DePuy Over Allegedly Faulty Hip Implant
- Pfizer Splits Into 3 Segments In Latest Shakeup
- The Noneffect Of Myriad On Personalized Medicine
- Perrigo Puts Up $8.6B For Elan
- China Bribery Crackdown May Trigger US, UK Investigations
- A-Rod's Cousin Tries To Duck Deposition In Drug Clinic Case
- Alcon Sues To Block Mylan's Bid For Generic Glaucoma Drug
- Medicare Change Heralds Easier Device Trial Reimbursements
- Teva MS Drug Patents Invalidated By Fed. Circ.
- Grunenthal Says Actavis, Alkem Infringed Painkiller IP
- Hansen Defendants To Pay $8.5M To Settle Investor Suit
- FDA Sounds Alarm Over J&J Antifungal Drug Nizoral
- Expert In Chinese Law Joins Greenberg Traurig IP Group
- Advanced Bionics Ear Injury Claims Escape Preemption
- EU Finds No Increase In Cancer Risk From Diabetes Drugs
- 7 Cases In Darvocet MDL Sent Back To State Court
- Smith & Nephew, Rival Company Drop Noncompete Suit
- Merck Attacks Watson, Actavis Over Birth Control Patent
- Class Dismissed: Recent Lessons From The Supreme Court
- What A US-China Investment Treaty Would Mean For US Cos.
- Edwards Tells Justices To Skip CoreValve Patent Case
- NECC Insolvency Ruling Will Pave Way For 3rd-Party Suits
- Sens. Introduce Revised Drug Compounding Bill
- S&N Settles $56M Trade Secrets Suit Against Contractors
- Rival Drug Data Co. Hits IMS Health With Antitrust Lawsuit
- GOP Questions Smithfield Deal's Effect On Heparin Supply
- Supplement Co. Can't Dodge False Ads Suit Over Creatine Line
- Medical Co. Denied Immediate Appeal Bid In Worker RICO Row
- Doctor Loses Bid To Block Bausch & Lomb's Slogan Use
- FDA Acknowledges Problems In Approach To Riskiest Drugs
- Fed. Circ. Rejects Bimeda Bovine Anti-Inflammatory Patent
- Mylan Settles With Orion Over Planned Stalevo Generic
- DLA Piper Patent Wiz Joins McGuireWoods' LA Office
- Novartis, Eisai Sue Rivals Over Planned Banzel Generics
- An Expert Out Of Her Element May Cost You
- Novartis Won't Face Punitives In Bone Drug Suit, Judge Says
- GSK's China Misadventures Put Heat On Foreign Drug Trials
- GSK To Pay $229M To Settle US Avandia Suits
- Natco Asks Fed Circ. To Reverse Gilead's Tamiflu Win
- Ropes & Gray To Investigate GSK Bribery Scandal In China
- Cornerstone Sues Exela Over Generic Hypertension Drug
- Drug Buyers Urge Class Cert. In Cephalon Off-Label Use Suit
- FDA Reveals Criteria For Importing Unapproved Drugs
- Deals Rumor Mill: Ally, Blackstone, Yankee Candle
- 500 Days Of The Revised Removal Statutes
- Aspen Dangles £700M Bid For GSK Drugs
- WL Gore Escapes Suit Over Heart Device Patent
- Be Sure To Include Method Claims In A Pharma Product App
- Generics Cos. Haven't Shaken Label Claims Post-Mensing
- Carter Ledyard Adds Patent Atty From Loeb & Loeb
- Medicis Conspired To Block Generic Solodyn, Suit Says
- MLB Won't Balk In Fla. Drug Clinic Case
- FDA Targets 15 Companies Over Bogus Diabetes Treatments
- Omnicare, Fla. Nursing Homes Settle Faulty Billing Suit
- FDA Wants Preemptive Lupus Treatment Suit Nixed
- Stryker Fax Recipients Urge Class Cert. Over TCPA Claims
- FTC Leader Backs Tough Pay-For-Delay Legislation
- And Now A Word From The Panel ...
- Medtronic Can't Duck Injury Suit Over Bone Graft Product
- GSK Claims R&D Misconduct In China Has Been Eliminated
- DC Circ. Affirms Execution Drug Import Ban
- Rainmaker Q&A: Miles & Stockbridge's Michael Brown
- Reilly Pozner Asks To Join GSK Avandia Class Action
- Another Ex-ArthroCare Exec Cops To $400M Fraud Scheme
- Shortcomings Of Best Practices Report On Drug Labeling
- 3rd Circ. Orders GSK To Trial Over Paxil Deal With Mylan
- Mylan Infringed Cephalon Painkiller Patents, Judge Says
- CORRECTED: HHS Sets Final Rule For Orphan Drugs Under 340B Program
- Fed. Circ. Won't Put DuPont On $18M Hook In Enzyme IP Case
- CVS Unfair Competition Claims Go To Arbitration, Judge Says
- ResMed Takes New ITC Action To Enforce Sleep Aid Patents
- Deals Rumor Mill: Dell, Onyx, Telefonica
- Bipartisan Bill Would Unlock User Fees For Drugs, Devices
- FDA Carves Out Broad Powers In Drug Inspections
- Ex-Bristol-Myers Exec To Forfeit Profits From Insider Trades
- EU Clears Baxter's $4B Gambro Buy With Conditions
- Gene Patents Won't Disappear Post-Myriad
- Rainmaker Q&A: Pachulski's Bradford Sandler
- Debating The Ethics Of Children's Organ Transplants
- GSK Says Execs May Have Broken Chinese Bribery Laws
- Teva, Amphastar Protected By Safe Harbor In IP Suit: Judge
- Boehringer Can't Shake Pradaxa Warning Label Claims
- Va. Court Urged To Reverse USPTO Neurological Patent Ruling
- SEC Sets The Bar Low In Suit Against SAC Boss Cohen
- NECC Victims Seek To Sue Others For Meningitis Outbreak
- FDA Reverses Course On Fecal Transplant Requirement
- Now Is The Time To Invest In Saudi Health Care Market
- Judges Warn Drug IP Attys To Dial Back Legal Maneuvers
- ITC Accepts Apex Consent Order, Ends ResMed Patent Probe
- Law360's Global 20 Firms Blaze New Trails Worldwide
- Pfizer Resolves 700 Suits In Chantix Depression MDL
- Marijuana Advocates Ask High Court To Mull Reclassification
- AbbVie Hits Roxane With Patent Suit Over Norvir
- Vivus Inks 11th-Hour Compromise To Avoid Proxy Fight
- Illumina, Complete Genomics Settle Patent Disputes
- DePuy Hits Ex-Sales Reps With Trade Secrets Suit
- DOJ Asked For More Details In Novartis Kickback Suit
- Mallinckrodt Pays $3.5M To Settle Kickback, FCA Claims
- Health Cos. Want Antitrust Cases Consolidated In Kan.
- Illumina Seeks To Overturn $115M Award In Patent Row
- Novartis Challenges Puerto Rican Drug Oversight In High Court
- Ranbaxy Sues First Databank For Trade Libel Over Acne Drug
- Merck To Pay $23M To Settle Vioxx Economic-Loss Claims
- Rainmaker Q&A: Cooley's Michael Rhodes
- The Best Rule Of Reason For Pay-For-Delay
- A Tough Year For Personal Care Products
- Riegel Loophole Keeps PMA Device Cases Afloat, Barely
- Teva Drug Would Infringe Mylan Patent, Judge Says
- Novartis Under Investigation Over MS Drug Marketing
- Pfizer, Takeda Units End Antitrust Case Over Protonix Patent
- Ex-ArthroCare CEO, CFO Indicted For $400M Earnings Fraud
- GSK Finance Exec Blocked From Leaving China, Co. Says
- Warburg Sells Drug Co. Talon In Backloaded $206M Deal
- ResMed, Apex Medical Fight Over Terms Of ITC Sleep Aid Deal
- Medicare Packaged Pay Will Squeeze High-Tech Hospital Care
- Choose Your mHealth Revenue Model Carefully
- Activist Rejects Settlement Offer Ahead Of Vivus Proxy Vote
- SigmaPharm Gets Skelaxin Suit Sent Back To Pa. Court
- FDA Urges Congress To Fix Compounding Oversight Issues
- Report Finds High Costs For Pay-For-Delay Drugs
- Activist Claims Vivus Proxy Vote Delay Cheats Shareholders
- Sandoz, Mylan Slip Teva Patent Suits Over MS Drug Research
- J&J To Pay $23M To Settle Investors' Drug Recall Suit
- Greenberg Traurig Adds Life Sciences Litigator In Atlanta
- K-V Pharma Gets Judge's Nod To Collect Ch. 11 Plan Votes
- 2nd Circ. Orders Schemer To Repay $10M To Morgan Stanley
- Rainmaker Q&A: Greenberg Traurig's Nancy Mitchell
- A Clear Guidance From OIG For Device Manufacturers
- J&J, Endo Pharma Units Face More Pelvic Mesh Claims
- DOJ Wants Ex-SAC Trader's Bid For Privileged Docs Quashed
- Abbott Shells Out $710M To Expand Heart, Eye Portfolio
- 8th Circ. Affirms Pfizer's Dismissal From Drug Injury Suit
- 5 More Countries Approve Pfizer Arthritis Drug Xeljanz
- Vivus Delays Annual Meeting, Blasts Activist Investor
- A Picture Of Health: Medical Tech Private Equity
- Edwards Wants Nerve-Tech Patent Nixed In Medtronic IP Row
- Leahy Wants NIH To Make Myriad License Out Patents
- Everett Hits Rival Acella With Supplement Patent Suit
- 4th Circ. Backs Remand Of W.Va. Zoloft Birth Defect Suits
- GSK Sent Bribes Through Travel Agencies, China Says
- The High Court's Dangerous Reset On Gene Patents
- SEC Probes Aveo Over Failed Renal Cancer Drug
- Bayer To Pay $74M To Settle Cipro Pay-For-Delay Fight
- FDA Details Structure Of Drugmakers' Pediatric Study Plans
- Testing Flaw May Affect Some Intuitive Devices, FDA Says
- GSK Dodges Putative Class Claims Over Avandia Payments
- FDA Warns Against Delaying Inspectors, Details Drug Seizures
- Philips Doles Out Vouchers To Settle AirFloss Suit
- Deals Rumor Mill: Smithfield, Swiss Re, GLG
- 10 Personal Liability Pitfalls For Directors And Officers
- USTR Urges India To Amend Solar, Drug Rules
- Medtronic Valve Sales Blocked In Germany In Edwards IP Row
- Watch The Hot Spots For Pharma Self-Regulation
- Rainmaker Q&A: Paul Hastings' Michael Fitzgerald
- Texas Suit Takes Aim At Johnson & Johnson Pelvic Mesh
- Bellwether Bard Case Ends In Mistrial For Improper Testimony
- FDA Still Under Gun On Antibiotics, Despite Hopeful Signs
- Sunovion Asks Fed. Circ. To Toss Lunesta Ruling
- USPTO Validates Bard Blood Vessel Patent In Blow To Gore
- Swanson Martin & Bell Beefs Up Product Liability Group
- UCB Launches Legion Of Suits To Protect Epilepsy Drug IP
- Myriad Sues Again To Block Rival Gene-Based Cancer Test
- Arthrex Can't Dodge KFx Patent Suit Over Suture IP
- FTC Seeks More Info On $8.5B Actavis-Warner Chilcott Merger
- GSK Execs Copped To Bribery, Tax Crimes, China Says
- Judicial Gatekeeping Suffers A Setback
- Pharmacy Compound Infringes Horse Drug Patents, Suit Says
- Stem Cell Patent Case Will Be Early Test Of Myriad's Reach
- Medical Device Cos. See Opening For Killing ACA's $30B Tax
- Holland & Knight Picks Up Ex-White Collar Prosecutor
- Hospitals Fire Back In Defense Of 340B Drug Discounts
- UK Regulator Blocks Wockhardt European Drug Sales
- Feds Order Farm To Stop Selling Antibiotic-Tainted Cattle
- 9th Circ.'s Rare Gift Of Time To Remove Case
- Myriad Sues Ambry Over Supreme Court-Backed Patents
- FDA Softens 'Dear Doctor' Letter Guidance For Drugmakers
- Goodwin Procter Snags Ex-Kirkland Life Sciences, IP Pro
- Synthes Bone Repair Patent Invalid, Fed. Circ. Rules
- Pain Now Or Later? Thermo Fisher Tastes Earnout Bitters
- India Panel Delays Vote On $1.6B Mylan, Agila Merger
- GOP Leaders Want Answers On ACA Employer Mandate Delay
- Support For Drug E-Labeling Mixed, GAO Says
- FDA's Generic-Drug Plan Will Live Or Die On Sameness Rule
- 7th Circ. Junks Overbilling Claims Against Walgreen, Par
- Pharmstandard To Spin Off OTC Unit, Buy Singaporean Co.
- Envision Pharmaceutical Announces Sale To TPG
- Silver Point Seeks Full Interest Payment In K-V Bankruptcy
- Bingham Adds Ex-DLA Piper IP, Litigation Pro In Tokyo
- FDA Gives Device Makers Few Ways Out Of Reporting Injuries
- Lance Armstrong, FRS Look To Sink Supplement Class Action
- Novartis Whistleblower Wants State FCA Claims Revived
- Myriad Illuminates High Court's Approach To Section 101
- HHS Floats Proposal To Upend Generic-Drug Labeling Regs
- GSK Sales Director Claims He Was Fired For Being A Man
- Teva's $1.6B Pfizer Patent Deal Isn't Covered, Insurer Says
- FDA Details Risk Reduction In Biologic Clinical Trials
- Thermo Fisher In $4M Suit For Alleged Post-Merger Scam
- Bayer Inks Deal With Cipro Buyers In Pay-For-Delay Suit
- Unigene Claims $64.2M Liabilities In Ch. 7 Petition
- Roche Defeats Class Cert. Bid In Canadian Accutane Action
- Purdue Sues Teva To Block 'Abuse-Proof' OxyContin Generic
- Baxano To Pay $6M To Settle FCA, Kickback Allegations
- Ex-Olympus Execs Get Suspended Sentences In Fraud Case
- Philips Hit With Class Action Over Unused Vacation Time
- Novartis Sues Accord Over Kidney Transplant Drug Patents
- Shipping Drugs To Ga. Just Got More Complicated
- Alpex Aims To Block Zydus' Generic Obesity Drug
- Generics Makers Escape NJ Accutane Mass Tort
- Fosamax Ruling Puts Preemption In Play For Branded Drugs
- Consumers Urge Fed. Circ. To Strike Down Stem Cell Patent
- Scope Of Statutory Research Exemption Remains Unresolved
- FTC V. Actavis: Reconciling Conflicts In Rule Of Reason
- BMS, Sanofi Pushed Docs To Overprescribe Plavix, Suit Says
- Par, Alkermes Sue Breckenridge To Block Generic Megace
- EU Adds Pharmaceuticals To Water Pollution Watch List
- Roche Pays $220 Million For Blood Testing Innovator
- Baxter Offers EU Antitrust Fixes On $4B Gambro Buy
- Weil Reps Avista Capital Fund In Dental Implant Deal
- Re-Exam Nixes Baxter's $23M Patent Win, Fed. Circ. Rules
- Medical Equipment Competitive Bids Start Despite Protests
- Lupin Hit With Suit Over Generic Prezista
- FDA Again Aims To Keep Misconduct Probes Secret
- Deals Rumor Mill: Carlyle, Providence Equity, Toksoz
- A Primer On WTO Dispute Settlement
- Chinese Police Detain GlaxoSmithKline Employees In Probe
- 11th Circ. Says Patent Claims Aren't Just For Fed. Circ.
- Morrison Dooms Part Of SAC Insider Case, Ex-Trader Says
- Merck Can't Duck Jury Award In Fosamax Bellwether Suit
- USPTO Defends Patent Term Adjustment Math To Fed. Circ.
- Davis Wright Flouted Ethics Rules In Coverage Row: Omeros
- FDA Details Steps For Streamlined Antibiotic Approval
- King & Spalding Adds Life Sciences, Health Expert In DC
- 9th Circ. ERISA Ruling Spurs Meritless Suits, Chamber Says
- Pfizer Files More Suits To Block Generic Toviaz
- AstraZeneca Sues Mylan Over Planned Vimovo Generic
- $10B Amgen Bid Snubbed By Onyx Pharmaceuticals
- Deals Rumor Mill: KKR, Blackstone, BC Partners
- Isolating The DNA Of Patent Damages
- Beware Of Malware: FDA On Cybersecurity Risks